stars 1 stars 2 stars 3

BendBio provides the core inertial microfluidics engine for next-generation cell therapy manufacturing systems. The Bottleneck: The growth of cell therapy has outpaced the evolution of its core processing tools. The industry remains reliant on legacy platforms like centrifugation, which are harsh on cells, difficult to automate, and introduce unacceptable process variability. Our Solution: We break this bottleneck with a proven, purpose-built platform for cell sorting, washing, concentration, and filtration. Our technology, exclusively licensed from Massachusetts General Hospital (MGH), enables a closed, continuous-flow process that delivers unmatched consistency, superior cell yield, purity, and viability. Engineered for OEM Integration: We empower our partners—instrument manufacturers and life science companies—by providing a validated, integration-ready subsystem. Our compact, scalable modules accelerate your time-to-market, de-risk your supply chain through our ISO 13485-certified manufacturing, and free your team to focus on instrument design and workflow innovation. Let's build your next-generation system.

BendBio Questions

Kyle Smith is the CTO and Co-Founder of BendBio.

2 people are employed at BendBio.

BendBio is based in Cambridge, Massachusetts.

Top BendBio Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users